S-1 Filing

SOLENO THERAPEUTICS INC CIK: 1484565

Filing Information

Form Type	S-1
Accession Number	`0001193125-15-382187`
Period End Date	20150930
Filing Date	20151119
Fiscal Year	N/A
Fiscal Period	N/A
XBRL Instance	capn-20150930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 77 Income Statement 80 Cash Flow Statement 106 Stockholders Equity 22 Comprehensive Income 1

Balance Sheet 77 line items

Line Item	Tag	Value	Unit	Period
Convertible preferred stock, shares authorized	`TemporaryEquitySharesAuthorized`	1.86M	shares	Point-in-time
Convertible preferred stock, shares outstanding	`TemporaryEquitySharesOutstanding`	865,429.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	10.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.72M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.96M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	6.77M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.32M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$64.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.27M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	535,685.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	6.77M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	6.77M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$149.60K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	535,685.00	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	535,685.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$94.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.32M	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$20.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$20.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$111.00K	USD	Point-in-time
Inventory	`InventoryNet`	$109.34K	USD	Point-in-time
Inventory	`InventoryNet`	$376.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$252.27K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$225.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$85.15K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.52M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.34M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.53M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$63.17K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$57.61K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$98.00K	USD	Point-in-time
Goodwill	`Goodwill`	$718.00K	USD	Point-in-time
Other intangible assets, net	`OtherIntangibleAssetsNet`	$946.00K	USD	Point-in-time
Total assets	`Assets`	$7.29M	USD	Point-in-time
Total assets	`Assets`	$8.40M	USD	Point-in-time
Total assets	`Assets`	$1.59M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$953.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$57.72K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$986.80K	USD	Point-in-time
Accrued compensation and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$128.65K	USD	Point-in-time
Accrued compensation and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$201.46K	USD	Point-in-time
Accrued compensation and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$1.22M	USD	Point-in-time
Series B warrant liability	`DerivativeLiabilitiesCurrent`	$3.85M	USD	Point-in-time
Line of credit and accrued interest	`LinesOfCreditCurrent`	$101.53K	USD	Point-in-time
Convertible promissory notes and accrued interest	`ConvertibleDebtCurrent`	$13.99M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.29M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.03M	USD	Point-in-time
Commitments	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments	`CommitmentsAndContingencies`	-	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$151.00K	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$2.55M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$18.30M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$1.46M	USD	Point-in-time
Total liabilities	`Liabilities`	$8.58M	USD	Point-in-time
Total liabilities	`Liabilities`	$19.59M	USD	Point-in-time
Common stock, value	`CommonStockValue`	$6.77K	USD	Point-in-time
Common stock, value	`CommonStockValue`	$536.00	USD	Point-in-time
Common stock, value	`CommonStockValue`	$12.00K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$59.14M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$82.10M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$19.24M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-57.10M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-70.34M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-83.40M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-37.86M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-11.19M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.29M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-34.20M	USD	Point-in-time
Liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$8.40M	USD	Point-in-time
Liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$7.29M	USD	Point-in-time
Liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$1.59M	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Government grant revenue	`RevenueFromGrants`	$155.00K	USD	1 Quarter
Government grant revenue	`RevenueFromGrants`	$220.00K	USD	3 Qtrs
Product revenue	`SalesRevenueGoodsNet`	$146.00K	USD	3 Qtrs
Product revenue	`SalesRevenueGoodsNet`	$92.00K	USD	1 Quarter
Total revenue	`Revenues`	$366.00K	USD	3 Qtrs
Total revenue	`Revenues`	$3.00M	USD	Annual
Total revenue	`Revenues`	$247.00K	USD	1 Quarter
Cost of product revenue	`CostOfRevenue`	$96.00K	USD	3 Qtrs
Cost of product revenue	`CostOfRevenue`	$56.00K	USD	1 Quarter
Gross profit	`GrossProfit`	$270.00K	USD	3 Qtrs
Gross profit	`GrossProfit`	$191.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.19M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$717.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.63M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.38M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.25M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.24M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$252.36K	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$96.00K	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$84.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$467.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$1.24M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.47M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$522.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.58M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$4.43M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.67M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$1.71M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$3.31M	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$1.32M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$8.92M	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$5.16M	USD	Annual
Total expenses	`OperatingExpenses`	$3.85M	USD	Annual
Total expenses	`OperatingExpenses`	$3.37M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-8.65M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-5.16M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-3.18M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.31M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-846.78K	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-1.32M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.08K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$1.77K	USD	Annual
Interest expense, net	`InterestExpense`	$752.00K	USD	1 Quarter
Interest expense, net	`InterestExpense`	$4.13M	USD	Annual
Interest expense, net	`InterestExpense`	$1.00K	USD	3 Qtrs
Interest expense, net	`InterestExpense`	$2.86M	USD	Annual
Interest expense, net	`InterestExpense`	$1.81M	USD	3 Qtrs
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$1.18M	USD	3 Qtrs
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$3.94M	USD	Annual
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$105.32K	USD	Annual
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$318.00K	USD	1 Quarter
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$-73.00K	USD	1 Quarter
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$895.00K	USD	3 Qtrs
Other expense	`OtherNonrecurringExpense`	$183.00K	USD	3 Qtrs
Other expense	`OtherNonrecurringExpense`	$183.00K	USD	1 Quarter
Inducement charge for Series C warrants	`PreferredStockConversionsInducements`	$3.05M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-4.41M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-1.97K	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-3.95M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-1.07M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-110.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-2.71M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.29M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.02M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.71M	USD	Annual
Net loss	`NetIncomeLoss`	$-13.06M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.39M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-13.24M	USD	Annual
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-10.42	USD	Annual
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-1.60	USD	3 Qtrs
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-11.24	USD	3 Qtrs
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-4.47	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-6.92	USD	Annual
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.33	USD	1 Quarter
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	10.04M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	535,685.00	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.18M	shares	3 Qtrs
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.27M	shares	Annual
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	535,648.00	shares	Annual
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	535,685.00	shares	3 Qtrs

Cash Flow Statement 106 line items

Line Item	Tag	Value	Unit	Period
Issuance of Common Stock to BDDI, Shares	`NoncashOrPartNoncashNumberOfSharesIssued`	50,000.00	shares	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.29M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.02M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.71M	USD	Annual
Net loss	`NetIncomeLoss`	$-13.06M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.39M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-13.24M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$42.11K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$20.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$48.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$28.52K	USD	Annual
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$5.00K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$38.42K	USD	Annual
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$345.44K	USD	Annual
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$144.00K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$746.00K	USD	3 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$21.00K	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$11.00K	USD	3 Qtrs
Loss on disposition of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-8.00K	USD	3 Qtrs
Loss on disposition of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-7.73K	USD	Annual
Loss on disposition of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-1.45K	USD	Annual
Change in fair value of preferred stock warrants	`ChangeInFairValueOfPreferredStockWarrants`	$888.00K	USD	3 Qtrs
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$1.18M	USD	3 Qtrs
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$3.94M	USD	Annual
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$105.32K	USD	Annual
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$318.00K	USD	1 Quarter
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$-73.00K	USD	1 Quarter
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$895.00K	USD	3 Qtrs
Change in fair value of common stock warrants	`ChangeInFairValueOfCommonStockWarrants`	$1.18M	USD	3 Qtrs
Non-cash interest expense relating to convertible promissory notes & amortization of discount on notes	`AmortizationOfDebtDiscountPremium`	$4.13M	USD	Annual
Non-cash interest expense relating to convertible promissory notes & amortization of discount on notes	`AmortizationOfDebtDiscountPremium`	$2.86M	USD	Annual
Inducement charge for Series C warrants	`InducedConversionOfConvertibleDebtExpense`	$3.05M	USD	3 Qtrs
Non-cash interest expense relating to line of credit	`LineOfCreditFacilityPeriodicPaymentInterest`	$1.53K	USD	Annual
Non-cash expense of issuing shares to Aspire Capital	`NoncashExpenseOnSharesIssued`	$183.00K	USD	3 Qtrs
Non-cash interest expense relating to warrants and convertible promissory notes	`PaidInKindInterest`	$1.81M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-149.60K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$94.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$149.60K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-112.00K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$109.34K	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$267.00K	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-150.78K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.56K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.67M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-27.00K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$101.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-161.80K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$353.90K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$103.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$542.00K	USD	3 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$229.00K	USD	3 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$720.00K	USD	3 Qtrs
Accrued compensation & other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$72.81K	USD	Annual
Accrued compensation & other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-62.36K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-6.92M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-885.22K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-2.93M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-6.92M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-4.48M	USD	Annual
Cash paid for purchase of assets of NeoForce Group, Inc.	`PaymentsToAcquireBusinessesGross`	-	USD	3 Qtrs
Cash paid for purchase of assets of NeoForce Group, Inc.	`PaymentsToAcquireBusinessesGross`	$1.00M	USD	3 Qtrs
Increase in restricted cash	`IncreaseInRestrictedCash`	$91.00K	USD	3 Qtrs
Cash paid for patent acquisition	`PaymentsToAcquireIntangibleAssets`	$150.00K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$48.00K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$30.68K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.27K	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-1.29M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-30.68K	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-1.27K	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	-	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.43M	USD	3 Qtrs
Proceeds from issuance of preferred stock warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$1.95K	USD	Annual
Proceeds from exercise of common stock options	`ProceedsFromStockOptionsExercised`	$294.00K	USD	3 Qtrs
Proceeds from issuance of convertible notes payable	`ProceedsFromConvertibleDebt`	$2.49M	USD	Annual
Proceeds from issuance of convertible notes payable	`ProceedsFromConvertibleDebt`	$2.00M	USD	3 Qtrs
Proceeds from line of credit	`ProceedsFromLinesOfCredit`	$100.00K	USD	Annual
Proceeds from Initial Public Offering	`ProceedsFromIssuanceInitialPublicOffering`	$10.73M	USD	Annual
Initial Public Offering costs paid	`PaymentsOfStockIssuanceCosts`	$276.00K	USD	3 Qtrs
Initial Public Offering costs paid	`PaymentsOfStockIssuanceCosts`	$2.12M	USD	Annual
Initial Public Offering costs paid	`PaymentsOfStockIssuanceCosts`	$530.00K	USD	3 Qtrs
Repayment of credit line	`RepaymentsOfLinesOfCredit`	$102.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.72M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$11.20M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$4.97M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-3.24M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-886.49K	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$6.69M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.21M	USD	3 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.72M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$7.96M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$64.00K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.27M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.72M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$7.96M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$64.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.27M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.16M	USD	Point-in-time
Patent costs included in Accrued liabilities	`PatentCostsIncludedInAccruedLiabilities`	$300.00K	USD	3 Qtrs
Reduction in initial public offering costs payable	`ReductionInInitialPublicOfferingCostsPayable`	$45.00K	USD	3 Qtrs
Cashless exercise of 2010/2012 warrants	`CashlessExerciseOfWarrant`	$13.00K	USD	3 Qtrs
Issuance of 50,000 shares of Common Stock as consideration for patent acquisition	`StockIssued1`	$112.00K	USD	3 Qtrs
Initial Public Offering costs accrued and included in Accounts Payable	`InitialPublicOfferingCostsIncludedInAccountsPayable`	$575.18K	USD	Annual
Issuance of restricted common stock in exchange for intellectual property	`IssuanceOfRestrictedCommonStockForIntellectualProperty`	$23.99K	USD	Annual
Beneficial conversion feature related to the warrants to purchase shares of convertible preferred stock in connection with convertible promissory notes	`DebtInstrumentConvertibleBeneficialConversionFeature`	$1.72M	USD	Annual
Issuance of warrants for the purchase of convertible preferred stock in connection with notes payable	`IssuanceOfWarrantsInConnectionWithNotesPayable`	$966.98K	USD	Annual

Stockholders Equity 22 line items

Line Item	Tag	Value	Unit	Period
Balances at beginning, Amount	`StockholdersEquity`	$-37.86M	USD	Point-in-time
Balances at beginning, Amount	`StockholdersEquity`	$-11.19M	USD	Point-in-time
Balances at beginning, Amount	`StockholdersEquity`	$-1.29M	USD	Point-in-time
Balances at beginning, Amount	`StockholdersEquity`	$-34.20M	USD	Point-in-time
Vesting of restricted common stock	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$23.99K	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.43K	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$345.44K	USD	Annual
Conversion of preferred stock to common stock in IPO	`ConversionOfStockAmountIssued1`	$23.81M	USD	Annual
Stock warrant liability reclassification/Issuance of warrants for overallotment exercise	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$1.22M	USD	Annual
Issuance of common stock in IPO (net of discounts & commission of $861,948)	`StockIssuedDuringPeriodValueNewIssues`	$9.85M	USD	Annual
Beneficial conversion feature in connection with related party convertible promissory notes	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$1.72M	USD	Annual
Deferred IPO costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$1.83M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.29M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.02M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.71M	USD	Annual
Net loss	`NetIncomeLoss`	$-13.06M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.39M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-13.24M	USD	Annual
Balances at end, Amount	`StockholdersEquity`	$-37.86M	USD	Point-in-time
Balances at end, Amount	`StockholdersEquity`	$-11.19M	USD	Point-in-time
Balances at end, Amount	`StockholdersEquity`	$-1.29M	USD	Point-in-time
Balances at end, Amount	`StockholdersEquity`	$-34.20M	USD	Point-in-time

Comprehensive Income 1 line items

Line Item	Tag	Value	Unit	Period
Issuance of common stock in IPO, discounts & commission	`DiscountAndCommissionOnIssuanceOfShares`	$861.95K	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.